ProCE Banner Activity

Advancing Care and Improving Survival for Patients With HER2-Positive Breast Cancer

Slideset

Get up to date on the APP’s evolving role in caring for patients with HER2-positive breast cancer, including molecular testing, treatment selection, and managing treatment-related adverse events.

Released: April 21, 2023

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner

Supporters

Supported by an educational grant from Seagen.

Seagen